Shanghai Allist Pharmaceuticals Co., Ltd.

¥87.47As of Sun 8 Nov 2026, 12:00 UTC
SSE:688578Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR 21.80%
Div yield 1.37%
ROE 37.63%
Biotechnology
Beta (5Y) 0.23
PE TTM 13.54
TSR TTM (17.67%)
Mkt cap ¥39.36B
ROIC 57.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥112
28.28%
33.85%
Hold 8|7|6|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.46
1.49
1.47
1.59
16.66%
11.44%
6.38%
8.36%
Revenue¥B
3.361
3.478
3.551
3.712
4.49%
9.44%
11.43%
16.66%
Peers (US$5.900B)
Cap (US$)
PE
6.899B
5.173x
4.882B
29.91x
Capital
TTM
5Y
10Y
Leveragex
8.319
(0.486)
(0.365)
EBIT/Intx
0.968
0.111
0.104
Own earn%
(551.80)
(7.72)
14.03
Sh yield%
18.11
42.21
42.09
Owners
Insiders/Inst%
14.62
56.56
Short interest%
4.60
SBC / revenue%
5.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
28–35
$1 testx
0.0
Incr. ROIC%
9